1. Lee Y, Jin C, Ohgaki R, Xu M, Ogasawara S, Warshamanage R, Yamashita K, Murshudov G, Nureki O, Murata T, Kanai Y. Structural basis of anticancer drug recognition and amino acid transport by LAT1. Nat Commun. 2025, 16(1), 1635, doi: 10.1038/s41467-025-56903-w.PMID: 39952931
2. Sui Y, Hoshi N, Okamoto N, Inoue Y, Funatsu T, Ku Y, Ooi M, Watanabe D, Miyazaki H, Agawa M, Nakamura H, Ohgaki R, Kanai Y, Yang H, Kodama Y. The role of LAT1 in AOM/DSS-induced colorectal tumorigenesis. Biochem Biophys Res Commun. 2025, 751, 151446, doi: 10.1016/j.bbrc.2025.151446.
3. Jin C, Zhou X, Xu M, Okanishi H, Ohgaki R, Kanai Y. Pharmacological and structural insights into nanvuranlat, a selective LAT1 (SLC7A5) inhibitor, and its N-acetyl metabolite with implications for cancer therapy. Sci Rep. 2025, 15(1), 2903, doi: 10.1038/s41598-025-87522-6.
4. Kaneda-Nakashima K, Shirakami Y, Hisada K, Feng S, Kadonaga Y, Ooe K, Watabe T, Manabe Y, Shimoyama A, Murakami M, Toyoshima A, Haba H, Kanai Y, Fukase K. Development of LAT1-Selective Nuclear Medicine Therapeutics Using Astatine-211. Int J Mol Sci. 2024, 25(22), 12386, doi: 10.3390/ijms252212386.
5. Liu Y, Ohgaki R, Okanishi H, Xu M, Kanai Y. Amino acid transporter LAT1 is expressed on cancer cell-derived exosomes with potential as a diagnostic and prognostic biomarker. Sci Rep. 2024, 14(1), 28458, doi: 10.1038/s41598-024-79425-9.
6. Taguchi R, Kaira K, Miura Y, Umesaki T, Mouri A, Imai H, Kagamu H, Yasuda M, Kanai Y, Nitanda H, Ishida H, Sakaguchi H. Prognostic significance of LAT1 expression in pleural mesothelioma. Heliyon. 2024, 10(17), e37414, doi: 10.1016/j.heliyon.2024.e37414.
7. Ohgaki R, Hirase Y, Xu M, Okanishi H, Kanai Y. LAT1 expression in colorectal cancer cells is unresponsive to HIF-1/2α accumulation under experimental hypoxia. Sci Rep. 2024,14(1), 19635, doi: 10.1038/s41598-024-70603-3.
8. Rosario FJ, Barentsen K, Powell TL, Urschitz J, Brown TL, Kanai Y, Jansson T. Trophoblast-specific overexpression of the LAT1 increases transplacental transport of essential amino acids and fetal growth in mice. PNAS Nexus. 2024, 3(6), pgae207, doi: 10.1093/pnasnexus/pgae207.
9. Saito S, Ando K, Sakamoto S, Xu M, Yamada Y, Rii J, Kanaoka S, Wei J, Zhao X, Pae S, Kanesaka M, Goto Y, Sazuka T, Imamura Y, Reien Y, Hamaguchi-Suzuki N, Saito S, Hirayama Y, Hashimoto H, Kanai Y, Ichikawa T, Anzai N. The LAT1 inhibitor JPH203 suppresses the growth of castration-resistant prostate cancer through a CD24-mediated mechanism. Cancer Sci. 2024, 115(7), 2461-2472, doi: 10.1111/cas.16191.